Abstract:Thioredoxin-interacting protein (TXNIP) plays a critical role in glucose metabolism and redox signaling. TXNIP has recently emerged as a potent tumor suppressor in various cancer models. In previous studies, we found TXNIP was activated by UNC0642, an inhibitor of histone methyltransferase, in MDA-MB-231 breast cancer cells. TXNIP activation was coupled with significant suppression of cell proliferation and tumor growth. In contrast, TXNIP knockdown increased MDA-MB-231 cell proliferation and in tumor growth and metastasis in vivo. TXNIP-reconstitution in TXNIP-deficient HCC1954 cells reduced cell proliferation and migration coupled with increased reactive oxygen species production. TXNIP-reconstitution also significantly decreased mitochondrial respiration, mitochondrial membrane potential and glycolysis in HCC1954 cells. To understand the mechanisms underlying TXNIP's antitumor activity, we performed co-immunoprecipitation and proteomic analyses to uncover TXNIP-interacting proteins. We identified calpastatin (CAST) as a novel TXNIP-interacting protein in breast cancer cells. CAST is an endogenous inhibitor of calpains, a family of calcium-activated cysteine proteases. Intriguingly, CAST association with TXNIP was readily detectable in TXNIP-low, but not in TXNIP-high breast cancer cells. The disassociation of CAST from TXNIP in TXNIP-high cells might allow CAST to inhibit calpain activity to augment TXNIP's antitumor function. Through RNAseq analysis, we identified a positive correlation between TXNIP expression and IL-24 activation in various breast cancer cells, which were also confirmed by western blotting. IL-24 has emerged as an important cancer therapy target because of its role in promoting cancer-specific apoptosis. Our data also demonstrated that TXNIP upregulated the level of IL-24 and downregulated STAT-3. Moreover, TXNIP exerts multifaceted effects on BC development through the IL24-STAT3 signaling axis, deepening our understanding of its complex role in the disease. Taken together, these studies identified novel TNXIP-dependent pathways and their potential new mechanisms in breast cancer pathogenesis with significant clinical implications. Citation Format: Jasvinder Singh, Bindeshwar Sah, Robert Clarke, Liang Liu. Identification of novel TXNIP-dependent antitumor pathways in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4378.

Supplementary Figure S2 from FBW7 (F-Box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the C-Myc/txnip (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer

Supplementary Figure S3 from FBW7 (F-Box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the C-Myc/txnip (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer

Data from FBW7 (F-Box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the C-Myc/txnip (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer

Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer

Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway

Abstract P2-16-02: TXNIP-dependent tumor suppressive pathways in breast cancer growth and progression

TXNIP-mediated crosstalk between oxidative stress and glucose metabolism

Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers

Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis

FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1

SUPPLEMENTARY figure 6 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

TXNIP regulates peripheral glucose metabolism in humans

TCF7L2 Positively Regulates Aerobic Glycolysis Via the EGLN2/HIF-1α Axis and Indicates Prognosis in Pancreatic Cancer

SUPPLEMENTARY figure 5 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

The Role of TXNIP in Cancer: a Fine Balance Between Redox, Metabolic, and Immunological Tumor Control

Abstract 4378: Identification of novel TXNIP-dependent antitumor pathways in breast cancer

Hepatic F-Box Protein FBXW7 Maintains Glucose Homeostasis Through Degradation of Fetuin-A.

FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells

Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer

W2476 represses TXNIP transcription via dephosphorylation of FOXO1 at Ser319

FGFBP1, a Downstream Target of the FBW7/c-Myc Axis, Promotes Cell Proliferation and Migration in Pancreatic Cancer.